Background Tranexamic acid (TXA) is a versatile antifibrinolytic agent that is widely used in
modern surgeries. This review assessed the safety and efficacy of intravenous (IV) TXA in …

Dental procedures have posed challenges in managing anticoagulated patients due to early
reports of oral hemorrhage. This study aims to evaluate the risks of postoperative bleeding …

Antifibrinolytic drugs are used extensively for on-demand treatment of severe acute
bleeding. Controlling fibrinolysis may also be an effective strategy to prevent or lessen …

Currently, the need for research in the field of hemostatic materials seems to be a necessity.
The purpose of this study was to prepare and assess a hemostatic polyurethane (PU) …

BACKGROUND Tranexamic acid (TXA) given early, but not late, after traumatic brain injury
(TBI) appears to improve survival. This may be partly related to TXA-driven profibrinolysis …

Background Tranexamic acid (TXA) has been hypothesized to mitigate coagulopathy in
patients after traumatic injury. Despite previous prehospital clinical trials demonstrating a …

Objective To conduct a systematic review and meta-analysis of randomized controlled trials
on the clinical efficacy and safety of prophylactic tranexamic acid (TXA) versus control …

Severe hemorrhage associated with trauma, surgery, and congenital or drug-induced
coagulopathies can be life-threatening and requires rapid hemostatic management via …

Abstract Background and Aims The purpose of this study was assessing the effect of local
injection of tranexamic acid (TXA) on the amount of bleeding during the primary rhinoplasty …

Background There is evidence that tranexamic acid (TXA) reduces surgical bleeding and is
widely used in trauma, obstetrics and other specialties. This practice is less well-established …